Pharma Surge

Pharma Surge

Pharmaceutical research team working in a modern facility

Clinical trial watch

Track phase updates, enrollment milestones, topline readouts, and study outcomes across the global drug development pipeline.

11 stories in the current channel snapshot

Advanced search
๐ŸŒdiscoverynews.google.com

Ceruvia Raises $8 Million to Advance Phase 1/2 Trial of Cluster Headache Therapy

citybizOriginal source
๐ŸŒdiscoverynews.google.com

Ceruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache

PA MediaOriginal source
๐ŸŒdiscoverynews.google.com

Altimmune (ALT) Begins Enrollment in Phase 3 Trial Amid High Pri

GuruFocusOriginal source
๐ŸŒdiscoverynews.google.com

Acurx receives FDA guidance on single Phase 3 trial pathway

Investing.comOriginal source
๐ŸŒdiscoverynews.google.com

Graham Heap Joins cAMPfield as R&D President to Advance Prifemilast Phase 2 Program

citybizOriginal source
๐ŸŒdiscoverynews.google.com

Moleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML

The Indian PractitionerOriginal source
๐ŸŒdiscoverynews.google.com

AIM ImmunoTech Announces Final Dose in Phase 2 DURIPANC Trial Ahead of Schedule for Ampligen in Metastatic Pancreatic Cancer

Quiver QuantitativeOriginal source
๐ŸŒdiscoverynews.google.com

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitorโ€™s Phase 3 Discontinuation

The Manila TimesOriginal source
๐ŸŒdiscoverynews.google.com

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

GlobeNewswireOriginal source
๐ŸŒdiscoverynews.google.com

Belite Bio presents updated phase 3 data on oral tinlarebant for Stargardt

Glance by Eyes On EyecareOriginal source
๐ŸŒdiscoverynews.google.com

Opus Genetics Completes Patient Enrollment in

GlobeNewswireOriginal source